Aikaterini Tsantikidi
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.
Journal: Translational oncology
Published: May 26, 2025
Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.
Journal: International journal of molecular sciences
Published: April 23, 2025
Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Journal: JCO precision oncology
Published: January 25, 2024
Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer.
Journal: Cancers
Published: September 27, 2023
The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking.
Journal: Diagnostics (Basel, Switzerland)
Published: August 11, 2023
RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis.
Journal: Oncology letters
Published: April 07, 2023
Comprehensive tumor molecular profile analysis in clinical practice.
Journal: BMC medical genomics
Published: October 25, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026